• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从在可溶性HIV-1包膜复合物上筛选出的一名HIV控制者体内获得的两种单链抗体片段-免疫球蛋白Fc段融合抗体的功能特性:一种中和性V3抗体和一种三聚体特异性gp41抗体。

Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

作者信息

Trott Maria, Weiβ Svenja, Antoni Sascha, Koch Joachim, von Briesen Hagen, Hust Michael, Dietrich Ursula

机构信息

Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.

HIV Specimen Cryorepository (HSC) at Fraunhofer Institute of Biomedical Engineering, St. Ingbert, Germany.

出版信息

PLoS One. 2014 May 14;9(5):e97478. doi: 10.1371/journal.pone.0097478. eCollection 2014.

DOI:10.1371/journal.pone.0097478
PMID:24828352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4020869/
Abstract

HIV neutralizing antibodies (nAbs) represent an important tool in view of prophylactic and therapeutic applications for HIV-1 infection. Patients chronically infected by HIV-1 represent a valuable source for nAbs. HIV controllers, including long-term non-progressors (LTNP) and elite controllers (EC), represent an interesting subgroup in this regard, as here nAbs can develop over time in a rather healthy immune system and in the absence of any therapeutic selection pressure. In this study, we characterized two particular antibodies that were selected as scFv antibody fragments from a phage immune library generated from an LTNP with HIV neutralizing antibodies in his plasma. The phage library was screened on recombinant soluble gp140 envelope (Env) proteins. Sequencing the selected peptide inserts revealed two major classes of antibody sequences. Binding analysis of the corresponding scFv-Fc derivatives to various trimeric and monomeric Env constructs as well as to peptide arrays showed that one class, represented by monoclonal antibody (mAb) A2, specifically recognizes an epitope localized in the pocket binding domain of the C heptad repeat (CHR) in the ectodomain of gp41, but only in the trimeric context. Thus, this antibody represents an interesting tool for trimer identification. MAb A7, representing the second class, binds to structural elements of the third variable loop V3 and neutralizes tier 1 and tier 2 HIV-1 isolates of different subtypes with matching critical amino acids in the linear epitope sequence. In conclusion, HIV controllers are a valuable source for the selection of functionally interesting antibodies that can be selected on soluble gp140 proteins with properties from the native envelope spike.

摘要

鉴于HIV-1感染的预防和治疗应用,HIV中和抗体(nAbs)是一种重要工具。长期感染HIV-1的患者是nAbs的宝贵来源。在这方面,包括长期不进展者(LTNP)和精英控制者(EC)在内的HIV控制者是一个有趣的亚组,因为在这里nAbs可以在相当健康的免疫系统中且在没有任何治疗选择压力的情况下随时间发展。在本研究中,我们对从一名血浆中有HIV中和抗体的LTNP产生的噬菌体免疫文库中选出的两个特定抗体进行了表征,这两个抗体被选为单链抗体片段(scFv)。该噬菌体文库在重组可溶性gp140包膜(Env)蛋白上进行筛选。对所选肽插入片段进行测序揭示了两类主要的抗体序列。相应的scFv-Fc衍生物与各种三聚体和单体Env构建体以及肽阵列的结合分析表明,一类以单克隆抗体(mAb)A2为代表,特异性识别位于gp41胞外域C七肽重复序列(CHR)口袋结合域中的一个表位,但仅在三聚体环境中识别。因此,该抗体是三聚体鉴定的一个有趣工具。代表第二类的mAb A7与第三个可变环V3的结构元件结合,并中和不同亚型的1级和2级HIV-1分离株,其线性表位序列中有匹配的关键氨基酸。总之,HIV控制者是选择功能有趣抗体的宝贵来源,这些抗体可以在具有天然包膜刺突特性的可溶性gp140蛋白上进行筛选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/f1433250ee65/pone.0097478.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/e1886154639b/pone.0097478.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/9471a51b46c5/pone.0097478.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/6d4ce28bc97e/pone.0097478.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/c944b906f927/pone.0097478.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/31261f8e3e17/pone.0097478.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/f1433250ee65/pone.0097478.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/e1886154639b/pone.0097478.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/9471a51b46c5/pone.0097478.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/6d4ce28bc97e/pone.0097478.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/c944b906f927/pone.0097478.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/31261f8e3e17/pone.0097478.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ff3/4020869/f1433250ee65/pone.0097478.g006.jpg

相似文献

1
Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.从在可溶性HIV-1包膜复合物上筛选出的一名HIV控制者体内获得的两种单链抗体片段-免疫球蛋白Fc段融合抗体的功能特性:一种中和性V3抗体和一种三聚体特异性gp41抗体。
PLoS One. 2014 May 14;9(5):e97478. doi: 10.1371/journal.pone.0097478. eCollection 2014.
2
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
3
A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.一种同时识别 HIV-1 包膜糖蛋白 V2-和 V3-聚糖表位的双特异性抗体比其亲本抗体更广泛和更有效。
mBio. 2020 Jan 14;11(1):e03080-19. doi: 10.1128/mBio.03080-19.
4
A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.HIV 感染精英控制者体内高度异常的 Env V1 区。
J Virol. 2019 May 1;93(10). doi: 10.1128/JVI.00094-19. Print 2019 May 15.
5
Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.MW965包膜蛋白中调节原发性HIV-1分离株中和表型及构象屏蔽潜力的新型结构决定因素的鉴定。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01779-17. Print 2018 Mar 1.
6
Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers.在完整的 HIV-1 Env 三聚体上,gp41-gp120 界面处的一个四分体、依赖裂解的表位的结构描绘。
Immunity. 2014 May 15;40(5):669-80. doi: 10.1016/j.immuni.2014.04.008. Epub 2014 Apr 24.
7
Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11.HIV-1 株 253-11 三级病毒中性化抵抗能力异常高的分子基础。
J Virol. 2018 Jun 29;92(14). doi: 10.1128/JVI.02261-17. Print 2018 Jul 15.
8
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.HIV-1包膜三聚体的功能稳定性影响其顶端对广泛中和抗体的可及性。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01216-17. Print 2017 Dec 15.
9
Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies.通过筛选免疫人噬菌体文库以对抗从具有广泛HIV-1中和抗体的患者(R2)分离出的包膜糖蛋白(gp140)而选择的交叉反应性HIV-1中和单克隆抗体。
Virology. 2007 Jun 20;363(1):79-90. doi: 10.1016/j.virol.2007.01.015. Epub 2007 Feb 15.
10
Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.未切割与成熟人免疫缺陷病毒膜包膜糖蛋白三聚体的比较。
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00277-18. Print 2018 Jun 15.

引用本文的文献

1
Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load.全面分析感染前抗体可鉴定与病毒血症控制和病毒载量相关的 HIV 靶标。
Front Immunol. 2023 Sep 6;14:1178520. doi: 10.3389/fimmu.2023.1178520. eCollection 2023.
2
Antibody Selection in Solution Using Magnetic Beads.溶液中使用磁珠进行抗体选择。
Methods Mol Biol. 2023;2702:261-274. doi: 10.1007/978-1-0716-3381-6_13.
3
Antibody Selection via Phage Display in Microtiter Plates.噬菌体展示技术在微孔板中进行抗体选择。

本文引用的文献

1
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.从猕猴免疫文库中开发抗肉毒杆菌神经毒素A轻链的中和单链抗体片段-免疫球蛋白融合蛋白
MAbs. 2014 Mar-Apr;6(2):446-59. doi: 10.4161/mabs.27773. Epub 2014 Jan 9.
2
Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.Cryo-EM 结构的完全糖基化可溶性裂解 HIV-1 包膜三聚体。
Science. 2013 Dec 20;342(6165):1484-90. doi: 10.1126/science.1245627. Epub 2013 Oct 31.
3
Crystal structure of a soluble cleaved HIV-1 envelope trimer.
Methods Mol Biol. 2023;2702:247-260. doi: 10.1007/978-1-0716-3381-6_12.
4
Construction of Human Immune and Naive scFv Phage Display Libraries.人免疫和初始 scFv 噬菌体展示文库的构建。
Methods Mol Biol. 2023;2702:15-37. doi: 10.1007/978-1-0716-3381-6_2.
5
Hybridoma technology: is it still useful?杂交瘤技术:它仍然有用吗?
Curr Res Immunol. 2021 Mar 22;2:32-40. doi: 10.1016/j.crimmu.2021.03.002. eCollection 2021.
6
Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2.关于针对SARS-CoV-2等新出现病原体的被动抗体疗法和基于肽的疫苗的观点。
Germs. 2021 Jun 2;11(2):287-305. doi: 10.18683/germs.2021.1264. eCollection 2021 Jun.
7
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.通过噬菌体展示技术开发用于诊断和治疗的针对传染病和毒素的重组抗体。
Front Cell Infect Microbiol. 2021 Jul 7;11:697876. doi: 10.3389/fcimb.2021.697876. eCollection 2021.
8
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.一种从 COVID-19 患者中筛选出的 SARS-CoV-2 中和抗体与 ACE2-RBD 界面结合,并且对大多数已知的 RBD 突变具有耐受性。
Cell Rep. 2021 Jul 27;36(4):109433. doi: 10.1016/j.celrep.2021.109433. Epub 2021 Jul 7.
9
Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.用于生物医学应用的传染病抗体:免疫抗体噬菌体文库库容量的小型综述。
Int J Biol Macromol. 2020 Nov 15;163:640-648. doi: 10.1016/j.ijbiomac.2020.06.268. Epub 2020 Jul 8.
10
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.基于蛋白质和肽的 HIV 进入抑制剂的开发,针对 gp120 或 gp41。
Viruses. 2019 Aug 1;11(8):705. doi: 10.3390/v11080705.
可溶性 HIV-1 包膜三聚体的晶体结构
Science. 2013 Dec 20;342(6165):1477-83. doi: 10.1126/science.1245625. Epub 2013 Oct 31.
4
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.高效中和 HIV-1 特异性单克隆抗体在感染猴免疫缺陷病毒的恒河猴中的治疗效果。
Nature. 2013 Nov 14;503(7475):224-8. doi: 10.1038/nature12744. Epub 2013 Oct 30.
5
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.抗体制剂免疫疗法抑制慢性感染猴 HIV 的病毒血症
Nature. 2013 Nov 14;503(7475):277-80. doi: 10.1038/nature12746. Epub 2013 Oct 30.
6
Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.裂解强烈影响可溶性 HIV-1 包膜糖蛋白三聚体是否采用天然样构象。
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18256-61. doi: 10.1073/pnas.1314351110. Epub 2013 Oct 21.
7
Neutralizing polyclonal IgG present during acute infection prevents rapid disease onset in simian-human immunodeficiency virus SHIVSF162P3-infected infant rhesus macaques.急性感染期间存在的中和多克隆 IgG 可预防感染猴免疫缺陷病毒 SHIVSF162P3 的幼年恒河猴迅速发病。
J Virol. 2013 Oct;87(19):10447-59. doi: 10.1128/JVI.00049-13. Epub 2013 Jul 24.
8
High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells.在 HEK293 细胞中高水平瞬时生产重组抗体和抗体融合蛋白。
BMC Biotechnol. 2013 Jun 26;13:52. doi: 10.1186/1472-6750-13-52.
9
Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals.非 B 群 HIV-1 感染者来源的人源抗 V3 单克隆抗体的交叉中和活性。
Virology. 2013 May 10;439(2):81-8. doi: 10.1016/j.virol.2012.12.010. Epub 2013 Mar 5.
10
HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.HIV-1 包膜三聚体与单体 gp120 具有相似的碳水化合物结合剂结合特征。
FEBS Lett. 2013 Apr 2;587(7):860-6. doi: 10.1016/j.febslet.2013.02.037. Epub 2013 Feb 26.